Creating Value-Based Metrics for Cancer Care: A Stakeholder-Informed, Evidence-Driven Approach
Putting the 'Economics' Back Into Health Economics Outcomes Research
From his vantage point as director of the Cancer Technology Assessment Group at the Fred Hutchinson Cancer Research Center in Seattle, Washington, Scott D. Ramsey, MD, PhD,sees the financial fallout of cancer care like few do.
Presentation 7: Where Does HEOR Fit in the Oncology Model?
According to Dr Ramsey, both the Health Economics Outcomes Research (HEOR) model and the pharmaceuticals pricing model in the United States are broken. He says: Unless we, as a community, figure out a way to use health economics in our decision making, we are not going to stop this train of unsupportable price increases in pharma.
Systematic Review of Comparative Effectiveness Data for Oncology Orphan Drugs
This study critically assessed the published clinical and economic evidence supporting oncology orphan drugs marketed in the United States.
Colony-Stimulating Factor Prescribing Patterns in Patients Receiving Chemotherapy for Cancer
We linked health insurance records to cancer registry data to analyze colony-stimulating factor use, finding wide divergence from that recommended by practice guidelines.
Preliminary Treatment Considerations Among Men With Newly Diagnosed Prostate Cancer
In a survey of local-stage prostate cancer patients, preference for prostatectomy was influenced by perceptions of its efficacy and personal burden versus nonsurgical options.
Second-line and Third-line Chemotherapy for Lung Cancer: Use and Cost
Using health insurance claims, we identified common first-, second-, and third-line chemotherapy regimens for patients with lung cancer and associated utilization and costs of care.
Toward Evidence-based Assessment for Coverage and Reimbursement of Laboratory-based Diagnostic and Genetic Tests
Genetic Testing and Pharmacogenomics: Issues for Determining the Impact to Healthcare Delivery and Costs
Technology Assessment of Medical Devices
The Limited State of Technology Assessment for Medical Devices: Facing the Issues
Estimated Costs of Treating Stress Urinary Incontinence in Elderly Women According to the AHCPR Clinical Practice Guidelines
2 Clarke Drive Cranbury, NJ 08512